Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2025.369 | Retention rate of adalimumab bio-original and biosimilars in rheumatic diseases: a real-world study from the Hong Kong Biologics Registry |
Dr. HO Ling Yin 何令妍 |
| 2025.495 | Comparison of clinical, pathological, immunological, and prognostic characteristics in patients with metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma and hepatitis B virus-related hepatocellular carcinoma who underwent hepatectomy: a multicenter study |
Dr. WONG Vincent 黃煒燊 |
| 2025.373 | A Phase 3, Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab Tirumotecan, MK-2870) Followed by Carboplatin/Paclitaxel vs Chemotherapy, Both in Combination With Pembrolizumab as Neoadjuvant Therapy for High-Risk, Early-Stage, Triple-Negative Breast Cancer or Hormone Receptor-low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer | Prof. YEO Winnie |
| 2025.422 | Comparison of visual outcomes with bilateral enhanced monofocal intraocular lenses versus mini-monovision with conventional monofocal intraocular lenses | Dr. KWOK Stephanie Hiu Wai |
| 2025.381 | A multicenter study on the clinicopathological and genetic features of myeloid neoplasms with isochromosome 17q | Dr. CHEUNG Joyce Sin |
| 2025.580 | Retrospective Review of Post-Irradiated Nasopharyngeal Carcinoma Patients with Osteoradionecrosis of the Nasopharynx |
Dr. LIAO Christopher Man Ka YEUNG |
| 2025.364 | A Randomised, Double-blind, Placebo-controlled, Parallel Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of Tezepelumab in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (JOURNEY) | Prof. HUI David Shu Cheong |
| 2025.387 | Outcomes for Robotics in Orthopaedic Joint Surgery | Prof. Chui Chun Sing |
| 2025.363 | Epidemiological analytics in the realm of big data for the enhancement of the understanding of orthopaedic conditions | Prof. LUI Pauline Po Yee |
| 2025.380 | Elucidation of tumour immune environment in lung cancer | Dr. Cheung Alvin |
| 2025.361 | Medication adherence patterns and treatment beliefs of patients using proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) | Dr. TSANG Chiu Chi |
| 2025.360 | Establishment of New Territories East Cluster Biliary Tract Cancer Database | Prof. CHAN Stephen Lam |
| 2025.395 | An Automatic Surgical Planning Assistant for Reverse Shoulder Arthroplasty Using Large Language Models |
Prof. CHUI Elvis Chun Sing Elvis Chun-Sing Chui |
| 2025.375 | tReatment Individualisation By EBV stratificatiON in nasopharyngeal carcinoma: an umbrella platform study (RIBBON-Umbrella) | Prof. MA Brigette Buig Yue |
| 2025.677 | 微生物菌群调控食管鳞状细胞癌免疫治疗的增敏机制与转化研究 (Mechanism and Application of Microbiota-Modulated Immunotherapy for Esophageal Squamous Cell Carcinoma (ESCC)) | Prof. CHEN Zigui |
| 2025.379 | Exploring the relationship between perceived stress, resilience level and coping skills among student midwives: A sequential mixed-methods design |
Prof. LAU Ying 劉櫻 |
| 2025.346 | The 2023 ACR/ EULAR Classification Criteria for the thromboembolic antiphospholipid syndrome: a validation study in Hong Kong Chinese patients |
Dr. TANG Hoi San 鄧凱珊 |
| 2025.345 | The 2023 ACR/ EULAR Classification Criteria for the thromboembolic antiphospholipid syndrome: a validation study in Hong Kong Chinese patients |
Prof. SO Ho 蘇皓 |
| 2025.344 | The 2023 ACR/ EULAR Classification Criteria for the thromboembolic antiphospholipid syndrome: a validation study in Hong Kong Chinese patients |
Dr. HO Ling Yin 何令妍 |
| 2025.348 | Understanding Mental Health Screening for Caregivers of Children with Developmental Concerns: Perspectives and Barriers Among Caregivers and Healthcare Providers Across Global Contexts | Dr. WONG Wing Ho |
| 2025.444 | Clinical utility of cerebrospinal fluid cell-free DNA/RNA for diagnosis of leptomeningeal metastasis of non-small cell lung cancer | Dr. LEUNG Joyce May Sum |
| 2025.349 | Spatial multi-omics analysis of tumor-infiltrating regulatory B cells in ovarian cancer with lymphotoxin overexpression in ovarian cancer typing diagnosis and recurrence prediction |
Prof. WANG Ronald 黃志超 |
| 2025.339 | Lung Cancer Biomarker: Methylation Risk Score for Early Detection and Minimal Residual Disease Monitoring | Dr. LI Siu Ching |
| 2025.432 | The First Phase Study to Evaluate the Safety of In-Vivo CAR-T Therapy for Patients with Refractory Systemic Lupus Erythematosus | Prof. Tam Lai Shan |
| 2025.438 | Optimising Postnatal Outcomes: Implementing the NuViva Programme |
Prof. POON Liona Chiu Yee 潘昭頤 |
| 2025.338 | Development of a Neurofeedback System to Support Emotion Visualization | Dr. WANG Yang |
| 2025.337 | Primary Obesity Surgery Endoluminal 2.0 (POSE-2) Procedure for Treatment of Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease |
Dr. NG STEPHEN KA KEI 吳家琦 |
| 2025.320 | Radiation-free Assessment of Skeletal Maturity and Bone Health Status in Paediatric Spinal Deformity | Dr. LAU Adam Yiu Chung |
| 2025.321 | Organoids derived from EUS-guided tissue sampling for precision oncology in advanced pancreatic ductal adenocarcinoma | Dr. XIA Xianfeng |
| 2025.430 | Validation Study of Cuffless Blood Pressure Monitoring Using Multi-Wavelength PPG and Single-Lead ECG | Prof. TSOI Kelvin |
| 2025.336 | Validation of the Hong Kong Database of Emotional Face (HKDEF) | Dr. WONG Wing Ho |
| 2025.332 | Self-management supported game-based exercise and massage to promote upper limb functions and psychological outcomes among people with spasticity after stroke: An exploratory trial | Prof. Lo Suzanne Hoi Shan |
| 2025.350 | The Development of an Intelligent System for Real-time Automated Anatomical Recognition System During Endoscopic Ultrasound | Prof. CHAN Shannon |
| 2025.324 | Establishment of Hong Kong Diabesity Register and a 3-year Randomized Clinical Trial for the Investigation of the Effectiveness of a Multicomponent Integrated Care Program in Chinese with Diabesity | Prof. KONG Alice Pik Shan |
| 2025.319 | App-assisted implementation of evidence-based management of acute intracerebral haemorrhage |
Dr. IP Bonaventure Yiu Ming 葉耀明 |
| 2025.356 | Development for AI-Powered Nasal Cavity Reconstruction | Prof. TONG Michael C.F. |
| 2025.351 | Long-term effects and healthcare costs of extreme heat on cardiovascular complications in Chinese patients with type 2 diabetes | Dr. LAU Siu Him |
| 2025.316 | Can biologic DMARD use retard syndesmophytes and facet joint arthritis progression and resolve axial inflammatory in psoriatic arthritis? A prospective follow up study using low-dose computed tomography and magnetic resonance imaging | Prof. TAM Lai Shan |
| 2025.352 | Review of hip fracture patients with history of fragility fracture | Dr. FUNG Kwun Ping |
| 2025.358 | Investigating the Predictive Power of Coronary Plaque for Major Adverse Cardiovascular Events (MACE) in Psoriatic Arthritis: A 10-year Retrospective Study | Prof. TAM Lai Shan |
| 2025.335 | Butyrate and Taurine to reduce chronic postsurgical pain in adult cardiac surgical patients: a Bayesian Optimized double-blinded randomized controlled trial | Dr. WONG Man Kin |
| 2025.331 | Effectiveness of a Game-based educational workshop on Hong Kong students’ change in self-efficacy, awareness, and attitudes to drug abuse | Prof. LI William Ho Cheung |
| 2025.334 | Healing with Exercises and Brain Stimulation: A Three-Arm Randomised Controlled Trial to Facilitate Symptom Control in Children with Attention-Deficit/Hyperactivity Disorder (ADHD) Living in Subdivided Flat Units | Dr. CHAN Crystal Ying |
| 2025.353 | An in-vitro study to examine the activity of Avibactam-aztreonam against Carbapenem resistant gram-negative bacilli in a tertiary referral laboratory in Hong Kong | Dr. LAI Christopher Koon Chi |
| 2025.330 | Effectiveness of Virtual Reality-enhanced Interventions on Preoperative Anxiety in Adults Undergoing Elective Surgery: A 3-arm randomised controlled trial (VIPA trial) | Mr. CHAN Sin Lun |
| 2025.359 | A two-part phase 1 open-label safety and pharmacokinetic study of intravenous RC220 in combination with doxorubicin in adult patients with solid tumours | Dr. LOONG Herbert Ho Fung |
| 2025.304 | Voice Link 2.0 AI Speech Recognition Investigation | Dr. FONG Raymond |
| 2025.303 | Voice Link 2.0 AI Speech Recognition Investigation | Dr. CHAN Edwin Ho Yin |
| 2025.355 | Retrospective Study Protocol – Data collection for AutoTV and AutoView |
Prof. LEE Alex Pui Wai 李沛威 |
| 2025.322 | Development and validation of a new scale to assess sexual problems in people with prostate cancer and to design an electronic patient-reported outcome measure for this population (ePROM-SexPCare) | Prof. NG Chi Fai |
Page 18 of 285.